From Queensland and Invercargill to the INR in Boca Raton, Florida September 11, 2014 720p

LEARN MORE: www.strokebrea...
REQUEST A CONSULTATION TODAY:
Additional Information:
Drugs. com: Perispinal Etanercept for Stroke Recovery - 2023 REVIEW bit.ly/3KvFJPe
Florida Doctor Gives Stroke Patients a New Shot at Mobility, Independence: bit.ly/3phc56k
Edward Tobinick, M.D. Information: bit.ly/36JE4Fx
Edward Tobinick, M.D. Google Scholar: bit.ly/3heyKvT
On Overcoming Barriers to Neuroinflammation Research (Tobinick, et al): bit.ly/3tcxIGf
LEARN MORE: www.strokebrea...
REQUEST A CONSULTATION TODAY:
SEE MORE STROKE VIDEOS: bit.ly/36BqvYx
UA-cam CHANNEL: bit.ly/3M5HbYk
CALL: [phone]
Two families, one from Queensland, Australia and the other from Invercargill, New Zealand, discuss their spouses improvements following treatment within the past week at the Institute of Neurological Recovery® in Boca Raton, 5 years and 3 years after stroke, respectively. Begins with husband discussing his wife Katie's improvements following treatment, and the reduced caregiver burden. Please be advised that individual results vary and some patients do not respond to treatment.
Chronic neurological dysfunction produced by stroke and traumatic brain injury has long been thought to be irreversible. A new scientific discovery by the INR®, as documented in this video, now promises to change current thinking about the potential for recovery of function, even years after the acute event.
Please see www.strokebreak... for more detailed information. Copyright 2014-2018 INR PLLC, all rights reserved, INR PLLC, Boca Raton, Florida. 720p video version.
Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. Treatment for this indication is off-label. Please see the Terms of Use (www.strokebreakthrough.com/about-the-institute/terms-of-use/). The method of treatment utilized is a patented invention of the INR®. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127 and 8236306, all assigned to TACT IP, LLC; and Australian patent 758523.